�鶹��ý

The �鶹��ý Trade Commission voted to issue a statement cautioning against reliance on prior advocacy statements and studies related to pharmacy benefit mangers (PBMs) that no longer reflect current...

Today, �鶹��ý Trade Commission Chair Lina M. Khan announced that an open meeting of the Commission will be held virtually on Thursday, July 20, 2023. The open meeting will commence at 11am ET and...

As part of its ongoing study on pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the �鶹��ý Trade Commission has issued a compulsory...

As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the �鶹��ý Trade Commission has issued compulsory...

The �鶹��ý Trade Commission announced that it will ramp up enforcement against any illegal bribes and rebate schemes that block patients’ access to competing lower-cost drugs. The enforcement policy...

The �鶹��ý Trade Commission announced today that it will launch an inquiry into the prescription drug middleman industry, requiring the six largest pharmacy benefit managers to provide information...

The �鶹��ý Trade Commission is extending the public comment period, until May 25, 2022, on a request for information that covers a wide range of issues in the PBM market – including contract terms...

The �鶹��ý Trade Commission announced it is soliciting public input on the ways that practices by large, vertically integrated Pharmacy Benefit Managers’ (PBMs) are affecting drug affordability and...

FTC Staff Comment Says New York Bill to Regulate Pharmacy Benefit Managers May Increase Pharmaceutical Prices for New York Consumers – �鶹��ý Trade Commission staff filed a comment stating that...

Commission approval of staff comments to the Virginia House of Delegates: The FTC has approved the filing of comments by the staffs of the Bureaus of Competition and Economics and the Office of Policy...

The �鶹��ý Trade Commission today issued a report entitled “Pharmacy Benefit Managers: Ownership of Mail-Order Pharmacies.” The report, developed in response to a Congressional request in the...